Tachyon Ventures invests in early-stage life sciences ventures at the forefront of medicine, biotech and bioengineering. We seek scientific teams pursuing ambitious goals and building platforms backed by industry-leading research and IP in the fields of immunotherapy, gene therapy / genetic engineering, organ engineering, and stem cell / regenerative medicine. We provide funding at pre-seed, seed and series A stage for teams with encouraging early test results, and a clear path-to-market.
6
Total Investments
5
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
About Tachyon Ventures
Recent Investments (6)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Mar 2021 | |
| Series B | •••••• | Mar 2021 | |
| Series A | •••••• | Jun 2020 | |
| Seed Round | •••••• | Mar 2020 | |
| Series B | •••••• | Feb 2020 | |
|
|
Series A | •••••• | Feb 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.